Related Experiment Video

Updated: Jul 9, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
10:19

A Murine Model of Group B Streptococcus Vaginal Colonization

Published on: November 16, 2016

Group B streptococcus: early- and late-onset infections

A Berardi1, C Tzialla, M Riva

  • 1Dipartimento Materno-Infantile, Università di Modena e Reggio Emilia, Italy. berardi.alberto@policlinico.mo.it

Journal of Chemotherapy (Florence, Italy)
|April 17, 2008
PubMed

Insights

Group B Streptococcus (GBS) is a major neonatal pathogen. Prevention efforts, including US guidelines, have decreased GBS disease incidence in newborns.

Area of Science:

  • Neonatal infectious diseases
  • Bacterial pathogenesis
  • Public health interventions

Background:

  • Group B Streptococcus (GBS) emerged as a significant neonatal pathogen in developed nations around the 1960s.
  • Disease incidence remained stable until the 1990s, coinciding with increased prevention strategies.
  • The implementation of American consensus guidelines in the mid-1990s has been linked to a reported decline in GBS disease in the US.

Purpose of the Study:

  • To review key challenges and strategies in preventing neonatal GBS infections.
  • To present epidemiological data on GBS disease in a northern Italian region.
  • To contextualize GBS disease within the broader landscape of neonatal infections and prevention.

Main Methods:

  • Literature review of GBS prevention strategies and neonatal disease trends.
  • Analysis of population-based data on GBS disease from a northern Italian region.
  • Synthesis of current knowledge on GBS pathogenesis and public health implications.

Main Results:

  • Prevention efforts, particularly in the US following guideline implementation, have shown success in reducing GBS disease incidence.
  • The review highlights the ongoing importance of GBS as a neonatal pathogen.
  • Initial population data from northern Italy are presented, offering new epidemiological insights.

Conclusions:

  • Effective prevention strategies are crucial for combating neonatal Group B Streptococcus infections.
  • Continued surveillance and regional data collection are essential for understanding and managing GBS disease.
  • The findings underscore the impact of public health initiatives on reducing the burden of neonatal bacterial infections.

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...